U.S. Markets close in 2 hrs, 43 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 9,040.19 | 589.00 | 6.97% |
| NASDAQ | 1,771.93 | 122.42 | 7.42% |
| S&P 500 | 964.49 | 65.27 | 7.26% |
| Day Low 09:30 AM EDT | 15.99 | |
|---|---|---|
| Day High 12:20 PM EDT | 19.205 |
|
| Range | 3.21 | |
| Volume | 253,830 | |
| 30-Day Avg. Vol. | 768,000 |
|
| Difference | -66.95% | |
| Market Cap. | 1.47 B | |
| Change | 158.63 M | |
| Shares Out. | 79.26 M | |
| Percent Traded | 0.33% | |
| Revenue (LFY) | 125.02 M | |
| Earnings (TTM) | -105.6 M | |
| Next Earnings | 12/10/2008 |
|
| EPS (TTM) | -1.11 |
| 52-Wk Low 7/7/08 | 13.29 | |
|---|---|---|
| 52-Wk High 1/22/08 | 25.25 |
|
| Range | 11.96 | |
| Prev. Close 10/10/08 | 17.14 | |
| Today's Open | 17.70 | |
| Change | 3.27% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 1.4337 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | -18.00 |
Regeneron isn't the Pentagon, but the company is fighting some serious enemies. Regeneron Pharmaceuticals develops protein-based drugs used to treat a variety of diseases and conditions, including cancer, ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | -0.324 3/31/08 | -0.15 3/31/08 |
0.174
Beat
|
| Last Quarter | -0.305 6/30/08 | -0.23 6/30/08 |
0.075
Beat
|
| Quarterly - 06/30/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 60.65 M | 125.02 M |
| Gross Profit | -5.92 M | -76.59 M |
| Operating Income | -19.39 M | -114.45 M |
| Net Income | -18.46 M | -105.60 M |
